Article Information
History
- August 2, 2024.
Article Versions
- Version 1 (March 21, 2024 - 08:52).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- YeunYi Lin1,*,
- Damien Leith1,*,
- Michael Abbott2,
- Rachael Barrett1,
- Samira Bell1,
- Tim Croudace3,
- Scott G Cunningham1,
- John F Dillon1,
- Peter T Donnan1,
- Albert Farre3,
- Rodolfo Hernández2,
- Chim Lang1,
- Stephanie McKenzie1,
- Ify R Mordi1,
- Susan Morrow4,
- H Cameron Munro5,
- Mandy Ryan2,
- Deborah J Wake6,7,
- H Wang1,
- Mya Win1,
- Ewan R Pearson1,# and
- the iDiabetes Study Team
- 1University of Dundee School of Medicine, Ninewells Hospital & Medical School, Dundee, DD1 9SY
- 2University of Aberdeen, Health Economics Research Unit, AB25 2ZD
- 3University of Dundee School of Health Sciences, 11 Airlie Pl, Dundee, DD1 4HJ
- 4Patient and Public Involvement (PPI) group representative and co-applicant
- 5GP and lead clinician Tayside Diabetes Managed Clinical Network
- 6Usher Institute, University of Edinburgh, Craigour House, Edinburgh, EH16 4SS
- 7MyWay Digital Health, University of Dundee School of Medicine, Ninewells Hospital & Medical School, Dundee, DD1 9SY
- ↵#Corresponding author; email: e.z.pearson{at}dundee.ac.uk
Posted August 02, 2024.
The iDiabetes Platform: Enhanced Phenotyping of Patients with Diabetes for Precision Diagnosis, Prognosis and Treatment - study protocol for a cluster-randomised controlled study in Tayside, Scotland
